Sun Pharmaceutical Entered Into Joint Venture with Intrexon Corporation

Oct 3, 2013 12:35 IST

Sun Pharmaceutical Industries India's biggest drug maker by market capital and USA based Intrexon Corporation, a leading player in synthetic biology announced on 2 October 2013 to establish a joint venture to develop controllable gene-based therapies for the treatment of eye diseases.

The joint venture will helpful for Sun Pharma's  to increase their global capabilities and experience in developing and manufacturing complex dosage forms .It will also enhance their specialty pharmaceuticals for niche therapy areas.

The partners will initially work on  age related macular degeneration ( AMD)(a medical condition that causes partial or full loss of vision among older adults), glaucoma(a kind of eye disease) and retinitis pigmentosa(an eye disease that causes severe vision loss and at times even blindness).

Is this article important for exams ? Yes12 People Agreed
Read more Current Affairs on: Sun Pharmaceutical , Intrexon , treatment of eye diseases

DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.

Latest Videos

Register to get FREE updates

    All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK